61,919 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by Moran Wealth Management LLC

Moran Wealth Management LLC bought a new position in Doximity, Inc. (NASDAQ:DOCS) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 61,919 shares of the company’s stock, valued at approximately $3,306,000.

Other large investors have also made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Doximity by 31.2% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 30,879 shares of the company’s stock valued at $1,649,000 after purchasing an additional 7,351 shares during the period. AlphaQuest LLC raised its position in Doximity by 213.2% in the fourth quarter. AlphaQuest LLC now owns 4,529 shares of the company’s stock valued at $242,000 after purchasing an additional 3,083 shares during the period. Larson Financial Group LLC raised its position in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after purchasing an additional 250 shares during the period. PNC Financial Services Group Inc. raised its position in Doximity by 6.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 10,278 shares of the company’s stock valued at $549,000 after purchasing an additional 631 shares during the period. Finally, Banco Santander S.A. raised its position in Doximity by 6.3% in the fourth quarter. Banco Santander S.A. now owns 15,794 shares of the company’s stock valued at $843,000 after purchasing an additional 939 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Performance

NASDAQ:DOCS opened at $60.48 on Tuesday. The company has a market capitalization of $11.29 billion, a price-to-earnings ratio of 60.48, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21. The stock has a 50-day simple moving average of $62.94 and a 200 day simple moving average of $51.99.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 37.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on DOCS shares. KeyCorp cut their price objective on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. Raymond James reissued an “outperform” rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Mizuho lifted their target price on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Canaccord Genuity Group lifted their target price on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Doximity presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.